Showing results (301-310 of 304) with videos related to
Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 304 results.
Journal of Medicinal Chemistry|September 1, 2020
Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine ProductionXiaohui Du, Jared Moore, Brian R Blank, et al.Science Advances|August 8, 2025
Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistanceMatthew T Klope, Poulami Talukder, Brian R Blank, et al.Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.Pageof 31